Search Results

Lexaria Bioscience Corp. announces the appointment of Nelson Cabatuan, CPA, as Chief Financial Officer (CFO) effective immediately.

Alcami Corporation, a leading contract development and manufacturing organization, announced the appointment of Rose-Marie Nelson as Chief Human Resources Officer.

Bayer announced Nelson Ambrogio as the new Head of the Radiology Business at its Pharmaceuticals Division, effective April 1, 2024.

Inspire Medical Systems, Inc. announced the retirement of Marilyn Carlson Nelson as Chair of its Board of Directors and the appointment of Chief Executive Officer Timothy P. Herbert to the additional role of Board Chair, to be effective at the conclusion of the Company’s Annual Meeting of Stockholders scheduled to occur on May 2, 2024.

HeartBeam, Inc. today announced the appointment of Ken Nelson and Mark Strome to its board of directors, effective as of June 5, 2023.

In 2023, the ADC market exceeded $10 billion, and this momentum is persisting into 2024, as evidenced by several strategic deals and a robust pipeline of candidate drugs.

With GLP-1 receptor agonists expected to dominate the weight loss market in the near term, several young companies are building on this mechanism, while others are taking a completely different approach.

In 2023, the ADC market exceeded $10 billion, and this momentum is persisting into 2024, as evidenced by several strategic deals and a robust pipeline of candidate drugs.

Kimer Med, a Nelson, New Zealand-based biotech start-up developing broad-spectrum antiviral compounds, today announced that it had achieved two 100% positive results in tests against the priority viruses Dengue (DENV-2) and Zika (ZIKV).